In this article, we will discuss Durvalumab (Warnings-34). So, let’s get started.
Infusion-Related Reactions
Durvalumab can cause severe or life-threatening infusion-related reactions.
Monitor for signs and symptoms of infusion-related reactions. Interrupt, slow the rate of, or permanently discontinue Durvalumab based on the severity. For Grade 1 or 2 infusion-related reactions, consider using pre-medications with subsequent doses.
Infusion-related reactions occurred in 2.2% (42/1889) of patients receiving Durvalumab, including Grade 3 (0.3%) adverse reactions.